Proposal of pharmacogenetics-based warfarin dosing algorithm in Korean patients (Q42750392)

6 November 2017

Proposal of pharmacogenetics-based warfarin dosing algorithm in Korean patients (English)

1 reference

6 November 2017

1 reference

Jung Ran Choi

1

1 reference

6 November 2017

Jeong-Oh Kim

2

1 reference

6 November 2017

Dae Ryong Kang

3

1 reference

6 November 2017

Seong-Ae Yoon

4

1 reference

6 November 2017

Jung-Young Shin

5

1 reference

6 November 2017

XiangHua Zhang

6

1 reference

6 November 2017

Mee Ork Roh

7

1 reference

6 November 2017

Hyung Joo Hong

8

1 reference

6 November 2017

Young-Pil Wang

9

1 reference

6 November 2017

Keon-Hyon Jo

10

1 reference

6 November 2017

Kwang-Soo Lee

11

1 reference

6 November 2017

Ho-Jung Yun

12

1 reference

6 November 2017

Yong-Seog Oh

13

1 reference

6 November 2017

Ki-Dong Yoo

14

1 reference

6 November 2017

Hee-Gyeong Jeon

15

1 reference

6 November 2017

Yoon Sook Lee

16

1 reference

6 November 2017

Tae Sun Kang

17

1 reference

6 November 2017

Hyun-Joo Park

18

1 reference

6 November 2017

Myeon Woo Chung

19

1 reference

6 November 2017

Jin-Hyoung Kang

20

1 reference

6 November 2017

17 February 2011

1 reference

Journal of Human Genetics

6 November 2017

1 reference

6 November 2017

56

1 reference

6 November 2017

290-295

1 reference

6 November 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/jhg.2011.4

6 November 2017

0 references

cites work

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen.

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

Genetic factors contribute to patient-specific warfarin dose for Han Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

The frequency of cytochrome P450 2C9 genetic variants in the Russian population and their associations with individual sensitivity to warfarin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

Validation and comparison of pharmacogenetics-based warfarin dosing algorithms for application of pharmacogenetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

Prospective study of warfarin dosage requirements based on CYP2C9 and VKORC1 genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

CYP2C9 and VKORC1 genotypes in Puerto Ricans: A case for admixture-matching in clinical pharmacogenetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

CYP4F2 genetic variant alters required warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

Pharmacogenomics: paving the path to personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

Genetic and clinical factors relating to warfarin dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

Validation of clinical testing for warfarin sensitivity: comparison of CYP2C9-VKORC1 genotyping assays and warfarin-dosing algorithms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

Pharmacogenetics of target genes across the warfarin pharmacological pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - rationale and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

Common VKORC1 and GGCX polymorphisms associated with warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements in an adult Turkish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

Evaluation of pharmacogenetic algorithm for warfarin dose requirements in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

Gamma-glutamyl carboxylase (GGCX) tagSNPs have limited utility for predicting warfarin maintenance dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

inferred from DOI database lookup

7 January 2021

based on heuristic

Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients

1 reference

https://api.crossref.org/works/10.1038%2FJHG.2011.4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/JHG.2011.4

1 reference

Dimensions Publication ID

6 November 2017

0 references

1 reference